Induction of cellular necrosis by the glutathione peroxidase mimetic ebselen

Journal of Cellular Biochemistry

Volumn 89, Issue 1, 2003, Pages 203-211

  Guérin, Paul J ^a   Gauthier, Eric R ^a  

^a LAURENTIAN UNIVERSITY   (Canada)

Author keywords

Antioxidant; Apoptosis; Ebselen; Hybridoma; Necrosis; Neuroprotection

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; EBSELEN; GLUTATHIONE PEROXIDASE; THIOPHENE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG EXPOSURE; DRUG INHIBITION; HYBRIDOMA CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ACETYLCYSTEINE; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIOXIDANTS; APOPTOSIS; AZOLES; CASPASES; CELL DEATH; CYCLOHEXIMIDE; CYSTEINE PROTEINASE INHIBITORS; GLUTATHIONE PEROXIDASE; HYBRIDOMAS; MICE; NECROSIS; ORGANOSELENIUM COMPOUNDS;

EID: 0344490255     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10500     Document Type: Article

References (39)

1. Boireau A, Dubedat P, Bordier F, Coimbra M, Meunier M, Imperato A, Moussaoui S. 1999. Effects of ebselen, a glutathione peroxidase mimic, in several models of mitochondrial dysfunction. Ann NY Acad Sci 893:254-257.
2. 2+/citrate in rat liver mitochondria. Neurosci Lett 289: 95-98.
3. Charbonneau JR, Gauthier ER. 2000. Prolongation of murine hybridoma cell survival in stationary batch culture by Bcl-xL expression. Cytotechnology 34:131-139.
4. Chen Y, Cai J, Murphy TJ, Jones DP. 2002. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem 277:33242-33248.
5. Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, Gustafsson J-A, Spyrou G. 2002. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 277:33249-33257.
6. Eguchi Y, Shimizu S, Tsujimoto Y. 1997. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57:1835-1840.
7. Eguchi Y, Srinivasan A, Tomaselli KJ, Shimizu S, Tsujimoto Y. 1999. ATP-dependent steps in apoptotic signal transduction. Cancer Res 59:2174-2181.
8. Engman L, Cotgreave I, Angulo M, Taylor CW, Paine-Murrieta GD, Powis G. 1997. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents. Anticancer Res 17:4599-4605.
9. Gauthier ER, Piché L, Lemieux G, Lemieux R. 1996. Role of bcl-xL in the control of apoptosis in murine myeloma cells. Cancer Res 56:1451-1456.
10. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770-776.
11. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I, Geuskens M, Kroemer G. 1997. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15:1573-1581.
12. Holl V, Coelho D, Silbernagel L, Keyser JF, Waltzinger C, Dufour P, Bischoff PL. 2000. Prevention of nitrogen mustard-induced apoptosis in normal and transformed lymphocytes by ebselen. Biochem Pharmacol 60:1565-1577.
13. Hoshida S, Aoki K, Nishida M, Yamashita N, Igarashi J, Hori M, Kuzuya T, Tada M. 1997. Effects of preconditioning with ebselen on glutathione metabolism and stress protein expression. J Pharmacol Exp Ther 281:1471-1475.
14. Imai H, Masayasu H, Dewar D, Graham DI, Macrae IM. 2001. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32:2149-2154.
15. Kitanaka C, Kuchino Y. 1999. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 6:508-515.
16. Kono H, Arteel GE, Rusyn I, Sies H, Thurman RG. 2001. Ebselen prevents early alcohol-induced liver injury in rats. Free Radic Biol Med 30:403-411.
17. Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B. 2000. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 275:33585-33592.
18. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. 1997. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 185:1481-1486.
19. Li QJ, Bessems JG, Commandeur JN, Adams B, Vermeulen NP. 1994. Mechanism of protection of ebselen against paracetamol-induced toxicity in rat hepatocytes. Biochem Pharmacol 48:1631-1640.
20. Li LY, Luo X, Wang X. 2001. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95-99.
21. Maulik N, Yoshida T. 2000. Oxidative stress developed during open heart surgery induces apoptosis: Reduction of apoptotic cell death by ebselen, a glutathione peroxidase mimic. J Cardiovasc Pharmacol 36:601-608.
22. Perreault J, Lemieux R. 1993a. Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas. Cytotechnology 13:99-105.
23. Perreault J, Lemieux R. 1993b. Rapid apoptotic cell death of B-cell hybridomas in absence of gene expression. J Cell Physiol 156:286-293.
24. Powis G, Gasdaska JR, Gasdaska PY, Berggren M, Kirkpatrick DL, Engman L, Cotgreave IA, Angulo M, Baker A. 1997. Selenium and the thioredoxin redox system: Effects on cell growth and death. Oncol Res 9: 303-312.
25. Ramakrishnan N, Kalinich JF, McClain DE. 1996. Ebselen inhibition of apoptosis by reduction of peroxides. Biochem Pharmacol 51:1443-1451.
26. Rybak LP, Husain K, Morris C, Whitworth C, Somani S. 2000. Effect of protective agents against cisplatin ototoxicity. Am J Otol 21:513-520.
27. 2 cells: Oxidant-induced caspase inactivation leads to necrosis. Biochem Biophys Res Commun 255:6-11.
28. Sane AT, Bertrand R. 1999. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death. Cancer Res 59:3565-3569.
29. Schewe T. 1995. Molecular actions of ebselen - An antiinflammatory antioxidant. Gen Pharmacol 26:1153-1169.
30. Shimohashi N, Nakamuta M, Uchimura K, Sugimoto R, Iwamoto H, Enjoji M, Nawata H. 2000. Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of jun-N-terminal kinase and the NF-kappab signaling pathway in rat Kupffer cells. J Cell Biochem 78:595-606.
31. Terlinden R, Feige M, Romer A. 1988. Determination of the two major metabolites of ebselen in human plasma by high-performance liquid chromatography. J Chromatogr 430:438-442.
32. Trump BF, Berezesky IK, Chang SH, Phelps PC. 1997. The pathways of cell death: Oncosis, apoptosis, and necrosis. Toxicol Pathol 25:82-88.
33. Ullrich V, Weber P, Meisch F, von Appen F. 1996. Ebselen-binding equilibria between plasma and target proteins. Biochem Pharmacol 52:15-19.
34. Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P. 1998. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187:1477-1485.
35. Wendel A, Fausel M, Safayhi H, Tiegs G, Otter R. 1984. A novel biologically active seleno-organic compound-II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem Pharmacol 33:3241-3245.
36. Yang CF, Shen HM, Ong CN. 2000a. Ebselen induces apoptosis in HepG(2) cells through rapid depletion of intracellular thiols. Arch Biochem Biophys 374:142-152.
37. Yang CF, Shen HM, Ong CN. 2000b. Intracellular thiol depletion causes mitochondrial permeability transition in ebselen-induced apoptosis. Arch Biochem Biophys 380:319-330.
38. Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. 2001. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 33: 616-626.
39. Zhao R, Masayasu H, Holmgren A. 2002. Ebselen: A substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc Natl Acad Sci USA 99:8579-8584.